Why Now
Think of someone you love who is over sixty. A parent. A partner. A close friend. Now consider what the next twenty years look like for them — statistically, probabilistically — if nothing changes. The cognitive decline. The cardiovascular disease. The cancer diagnosis that comes “at their age.” The slow loss of independence, of vitality, of the person you know.
Now consider that this trajectory is not inevitable. That the biological processes driving it are understood, targetable, and in some cases already being reversed in human clinical trials. That the scientists working on this are not dreamers — they are some of the most rigorous researchers in the world, working at institutions like the Buck Institute, Stanford, and Columbia, supported by federal programs and private investment that has never been larger.
The question is not whether this science is real. It is. The question is how quickly the world comes to understand that — and whether that understanding arrives in time to matter for the people we love.
That is what ALSAE is working to accelerate.
The science is advancing faster than most people know. What isn’t keeping pace is the cultural understanding that makes it possible for the world to receive it, demand it, and fund it. ALSAE is the first organization dedicated to connecting longevity science with the arts and entertainment industries — building the cultural layer that determines how quickly this scientific moment becomes something the world is ready to act on.
We Have Done This Before
Every generation has faced a defining health challenge. Every generation has found a way through.
Centuries ago, contaminated water and poor sanitation killed millions. Then we built clean water systems, and that threat receded. Bacterial infections decimated populations — until antibiotics arrived, and tuberculosis and pneumonia became survivable. Smallpox and polio once defined entire generations by the suffering they caused. Vaccines made them history.
In each case, the solution seemed impossible until it was achieved. In each case, the breakthrough required not just science, but a civilization that had decided the problem was worth solving.
We are at that inflection point again. The diseases that now define aging — Alzheimer’s, cardiovascular disease, cancer, diabetes — are the next chapter of this same story. And the science to address them is not waiting for some distant future. It is happening now.
These Diseases Share a Common Root
Alzheimer's, cancer, heart disease, and diabetes are not separate misfortunes. They are different expressions of the same biological process.
Age-related diseases such as heart disease, cancer, Alzheimer’s, and diabetes are not isolated conditions. Rather, they are the result of biological damage and cellular degradation that accumulate as we age—a unifying insight at the core of geroscience, the study of the biological mechanisms of aging. Over time, our bodies experience a breakdown in various processes—damage to our DNA, the failure of cells to divide properly, and the buildup of harmful molecules in tissues. These changes create the conditions for diseases to develop, making aging the biggest risk factor for many of the most common illnesses.
Scientists have identified hallmarks of aging—key processes such as DNA damage, chronic inflammation, and impaired cellular repair—that contribute to the onset of these diseases. While each disease may manifest differently, they share a common set of biological drivers that emerge as we age.
By understanding these shared pathways of damage and degradation, we have identified the underlying factors that contribute to a wide range of age-related diseases. Although the exact mechanisms that lead to these diseases are still being studied, we know that these fundamental biological changes create a window for intervention. This discovery offers us a critical opportunity: to develop therapies that target these pathways and reduce the risk of age-related diseases, preventing them from taking hold or reversing their impact once they develop.
The Science Is Real. The Progress Is Now.
These are not hypothetical futures. These are the tools scientists are using today.
The biological hallmarks that drive age-related diseases are now well-understood. The therapies targeting them are already in development — and in some cases already in clinical trials, already producing measurable results in human beings.
Innovations in gene editing, stem cell therapies, and regenerative medicine are rapidly advancing our ability to repair damaged tissues, regenerate lost cells, and intervene in the processes that drive disease. In addition, cellular reprogramming offers the potential to reverse some of the cellular damage that occurs as we age, effectively rejuvenating aging cells. Senolytic therapies aim to remove damaged, senescent cells that contribute to inflammation and tissue degradation, while AI-driven drug discovery is accelerating the development of highly targeted treatments. Epigenetic research is also unlocking new ways to influence gene expression and reduce the harmful effects of aging.
By supporting and accelerating the development of these emerging technologies, we can help move closer to a future where we no longer face the inevitability of diseases like heart disease, cancer, and Alzheimer’s. The potential is enormous, and with continued investment and public support, these breakthroughs could transform the way we treat, and ultimately prevent, age-related diseases for generations to come.
This Is Personal. It Will Be Personal for Everyone.
Not as a statistic. Not as a policy question. As the person you will watch decline, or the person you will become.
You are on an inevitable collision course with the diseases of aging — all of them, on a long enough timeline. So is everyone you love.
The financial cost is staggering — more than $1 trillion annually in direct treatment costs globally, with the burden rising as populations age. But the numbers fail to capture what actually happens. The cost of inaction is more than financial.
Age-related diseases rob individuals of their independence, vitality, dignity, and ability to contribute meaningfully to society. Entire generations are removed from the workforce or severely limited by illness, becoming dependent on others for basic needs. Meanwhile, caregivers dedicate their time and energy to managing these chronic conditions, rather than contributing to societal progress.
By investing in research and technologies that aim to prevent and reverse age-related diseases, we have the opportunity to significantly reduce this burden, alleviate suffering, and unlock the full potential of future generations.
The science to change this trajectory is advancing. What it needs is a world that understands it’s possible — and demands it.
The science to prevent and cure the diseases of aging is advancing. What determines how quickly it reaches the world is culture — and that is what ALSAE is building.
ALSAE is building that moment — and we are inviting a select community of artists, scientists, and visionary partners to help.
Explore Vision Circle membership — join@alsae.org
